NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Creative Enzymes' AI-Integrated Biocatalysis Platform
Creative Enzymes has launched an AI-driven biocatalysis platform that accelerates enzyme development by merging computational engineering with practical process know-how. The platform reduces development cycles from 12-24 months to 8-12 months, lowers costs, and enables access to previously inaccessible molecules.
The platform aims to accelerate enzyme catalyst development for biomanufacturing by integrating AI with hands-on process development, delivering predictable and practical solutions at industrial scale.
AI adds value by predicting enzyme candidates for specific reactions, designing enzymes constrained by process parameters rather than biology, and using molecular features to anticipate process performance in advance.
Benefits include faster development cycles (8-12 months vs. 12-24 months), reduced R&D costs by minimizing experimental testing, lower risk of process failure, and access to molecules previously inaccessible to enzymatic conversion.
The three modules are AI-Driven Biocatalysis Solutions (end-to-end discovery and engineering), AI-Driven Industrial Biocatalysis (lab-to-commercial scale), and AI-Driven Green Biocatalysis (sustainability-focused solutions).
Quantitative data is passed from each stage of the workflow to the next, ensuring decisions are driven by empirical evidence rather than theoretical assumptions.
Key parameters include temperature, pH, solvent, substrate loading, and cofactor availability.
It addresses substrate concentration optimization, cofactor regeneration, product inhibition management, immobilization, formulation development, process analytical technology integration, and delivery of technology transfer packages including SOPs and regulatory documentation.
It provides sustainability-focused solutions that align with corporate environmental goals and regulatory trends, using aqueous media at room temperature to minimize organic solvent use.
The platform is aimed at biomanufacturing companies and researchers needing efficient enzyme development for industrial applications.